Cytek Biosciences (CTKB) earnings call transcripts

Management framed Q2 as evidence of U.S. and China momentum, while emphasizing new products and recurring revenue as longer-term growth drivers.

Management framed Q1 as a return toward normal U.S. demand, with recurring revenue and product breadth offsetting regional disruptions and macro uncertainty. U.S.